A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease



Status:Completed
Conditions:Alzheimer Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:50 - 89
Updated:11/25/2017
Start Date:December 2008
End Date:December 2012

Use our guide to learn which trials are right for you!

A Randomized, Double-Blind, Placebo-Controlled, Two Dose Arm, Parallel Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

The purpose of this study was to evaluate the efficacy and safety of 2 doses of Immune
Globulin Intravenous (IGIV), 10% administered every 2 weeks as an intravenous (IV) infusion
compared with placebo in participants with mild to moderate Alzheimer's disease (AD).

Study visits: Each participant will be tested at the investigational site, and if qualified,
will be treated intravenously (through a vein) every two weeks for 70 weeks (approximately 18
months). The first three infusions must be done at the site, but if the infusions are well
tolerated, subsequent infusions may be done by a qualified healthcare provider in the home or
other suitable location. Each participant must return to the site every 3 months for
evaluation of cognition as well as blood tests and scans of the brain.

Main Inclusion Criteria:

- Written informed consent - participant (or participant´s legally acceptable
representative) and caregiver who are willing and able to participate for the duration
of the study

- Diagnosis of probable Alzheimer´s Disease (AD)

- Dementia of mild to moderate severity defined as mini-mental state examination (MMSE)
16-26 inclusive at the time of screening

- Neuroimaging (computed tomography [CT] or MRI) performed after symptom onset
consistent with AD diagnosis

- Ability to comply with testing and infusion regimen, including fluency in English or
Spanish, adequate corrected visual acuity and hearing ability

- On stable doses of regulatory authority approved AD medication(s) for at least 3
months prior to screening. These medications must be continued throughout this study.

- If receiving psychoactive medications (e.g. antidepressants other than monoamine
oxidase inhibitors (MAOIs) and most tricyclics, antipsychotics, anxiolytics,
anticonvulsants, mood stabilizers, etc), must be on stable doses for at least 6 weeks
prior to screening

Main Exclusion Criteria (Reasons why it might not be appropriate to participate):

- Any other forms of dementia

- Medical issues that might increase the risk of treatment with IGIV, 10%, such as:

1. Significant problems with blood pressure, heart disease, clotting disorders,
strokes or recent heart attacks

2. Evidence of current bleeding in the brain by MRI

3. Serious problems with the liver or kidneys

4. Allergies to blood products

- Medical issues that might interfere with the evaluation of the treatment of dementia
or might make dementia worse, such as:

1. Diabetes

2. Recent treatment with chemotherapy or immune suppression

3. The recent use of other investigational drugs, especially antibody therapy for AD

4. Severe headaches or psychiatric problems
We found this trial at
38
sites
1438
mi
from
Burlington, MA
Click here to add this to my saved trials
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
610
mi
from
Chicago, IL
Click here to add this to my saved trials
895
mi
from
Cleveland, OH
Click here to add this to my saved trials
349
mi
from
Dallas, TX
Click here to add this to my saved trials
622
mi
from
Franklin, TN
Click here to add this to my saved trials
429
mi
from
Iowa City, IA
Click here to add this to my saved trials
1152
mi
from
Irvine, CA
Click here to add this to my saved trials
196
mi
from
Kansas City, KS
Click here to add this to my saved trials
1118
mi
from
La Jolla, CA
Click here to add this to my saved trials
971
mi
from
Las Vegas, NV
Click here to add this to my saved trials
725
mi
from
Lexington, KY
Click here to add this to my saved trials
1190
mi
from
Liverpool, NY
Click here to add this to my saved trials
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
574
mi
from
Madison, WI
Click here to add this to my saved trials
1323
mi
from
Miami Beach, FL
Click here to add this to my saved trials
National City, California 91950
1140
mi
from
National City, CA
Click here to add this to my saved trials
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
1290
mi
from
New York, NY
Click here to add this to my saved trials
North Charleston, South Carolina 29406
1055
mi
from
North Charleston, SC
Click here to add this to my saved trials
262
mi
from
Omaha, NE
Click here to add this to my saved trials
1154
mi
from
Orange, CA
Click here to add this to my saved trials
702
mi
from
Paw Paw, MI
Click here to add this to my saved trials
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
1383
mi
from
Portland, OR
Click here to add this to my saved trials
1424
mi
from
Providence, RI
Click here to add this to my saved trials
515
mi
from
Rochester, MN
Click here to add this to my saved trials
1122
mi
from
Rochester, NY
Click here to add this to my saved trials
418
mi
from
Saint Louis, MO
Click here to add this to my saved trials
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
1143
mi
from
Sarasota, FL
Click here to add this to my saved trials
859
mi
from
Sun City, AZ
Click here to add this to my saved trials
1117
mi
from
Tampa, FL
Click here to add this to my saved trials
833
mi
from
Tucson, AZ
Click here to add this to my saved trials
156
mi
from
Tulsa, OK
Click here to add this to my saved trials
1486
mi
from
Vancouver,
Click here to add this to my saved trials
1126
mi
from
Washington, D.C.,
Click here to add this to my saved trials